Inactive Instrument

Press Releases Proteo, Inc. Other OTC

Equities

PTEO

US74369R3084

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PROTEO INC : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	20-07-20	AQ
PROTEO INC : Submission of Matters to a Vote of Security Holders (form 8-K)	20-07-10	AQ
PROTEO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	20-06-05	AQ
PROTEO INC : Other Events (form 8-K)	20-05-12	AQ
PROTEO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	20-05-07	AQ
PROTEO INC : Other Events (form 8-K)	20-03-30	AQ
PROTEO INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	20-03-03	AQ
Proteo Inc : Patient recruitment and treatment in Elafin CABG Phase II clinical trial completed	13-11-08	PU
PROTEO INC : Proteo, Inc. / Proteo Biotech AG: EMPIRE-Study recruits first coronary bypass patients	11-08-16	PU
PROTEO INC : Proteo, Inc./ Proteo Biotech AG: Proteo's Elafin Will Be Tested at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)	10-06-18	BU
PROTEO : Proteo, Inc./Proteo Biotech AG: Clinical Study in Harvard Reveals Elafin Deficiency in Acute Respiratory Distress Syndrome (ARDS)	09-02-17	BU
PROTEO : Inc./Proteo Biotech AG - Minapharm/Rhein Minapharm Biogenetics SAE: Approval for a Phase II Clinical Trial with Elafin in Kidney Transplantation	08-12-10	BU
PROTEO : Proteo, Inc./Proteo Biotech AG: Start of the Phase II clinical trial with Elafin	08-11-17	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer